Discover

KVUE
Kenvue Inc.
17.49
20600 x 17.49
22600 x 17.50
bid
ask
+
0.00
0.00%
21600 @ 04:00 PM
17.43 -0.06 (0.34%)
Ytd 1.39%
1y -23.12%
17.41
day range
17.68
14.11
52 week range
24.44
Open 17.58 Prev Close 17.49 Low 17.41 High 17.68 Mkt Cap 33.58B
Vol 6.57M Avg Vol 33.89M EPS 0.76 P/E 23.01 Forward P/E 14.51
Beta 0.57 Short Ratio 2.55 Inst. Own 96.07% Dividend 0.83 Div Yield 4.79
Ex Div Date 02-11 Earning 05-07 50-d Avg 17.87 200-d Avg 18.06 1yr Est 19.58
Earning
Date For Estimate Reported Surprise surprise %
2026-05-14 2026-03 0.27 N/A N/A N/A
2026-02-17 2025-12 0.22 0.27 0.05 22.73%
2025-11-03 2025-09 0.27 0.28 0.01 3.70%
2025-11-03 2025-09 0.27 N/A N/A N/A
2025-08-07 2025-06 0.28 0.29 0.01 3.57%
2025-08-07 2025-06 0.28 N/A N/A N/A
Upgrade / Downgrade
Date Firm Action From To
2026-04-15 Citigroup Upgrade Neutral Neutral
2026-04-14 Barclays Upgrade Equal-Weight Equal-Weight
2026-04-07 UBS Upgrade Neutral Neutral
2026-03-06 Barclays Upgrade Equal-Weight Equal-Weight
2026-02-18 Canaccord Genuity Upgrade Hold Hold
2026-02-18 Citigroup Upgrade Neutral Neutral
Profile
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
Insider Holder
Date Name Relation Quantity Description
2026-03-09 ALVARADO LUANI Chief Operating Officer 61.42K Conversion of Exercise of derivative security
2026-03-09 LAWSON CARLTON Officer 111.42K Conversion of Exercise of derivative security
2025-03-04 MONGON THIBAUT Chief Executive Officer 216.47K Conversion of Exercise of derivative security
2025-12-14 ORLANDO MATTHEW General Counsel 38.08K Conversion of Exercise of derivative security
2025-12-14 PERRY KIRK L Chief Executive Officer 62.55K Conversion of Exercise of derivative security
2025-03-04 RUH PAUL Chief Financial Officer 56.20K Conversion of Exercise of derivative security
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Vanguard Group Inc 234.95M 4.11B 12.24%
2025-12-30 Blackrock Inc. 159.55M 2.79B 8.31%
2025-12-30 State Street Corporation 118.87M 2.08B 6.19%
2025-12-30 FMR, LLC 94.11M 1.64B 4.90%
2025-12-30 Massachusetts Financial Services Co. 68.49M 1.20B 3.57%
2025-12-30 Pentwater Capital Management Lp 56.72M 991.19M 2.95%
Fund Ownership
Report Date Organization Position Value Percentage
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 60.21M 1.05B 3.14%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard 500 Index Fund 48.31M 844.18M 2.52%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund 41.70M 728.69M 2.17%
2026-02-27 Fidelity Concord Street Trust-Fidelity 500 Index Fund 24.38M 426.06M 1.27%
2026-02-27 iShares Trust-iShares Core S&P 500 ETF 24.44M 427.04M 1.27%
2026-03-30 SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust 22.26M 388.99M 1.16%
Dividend
Dividend Date
0.2075 2026-02-11
0.2075 2025-11-12
0.2075 2025-08-13
0.205 2025-05-14
0.205 2025-02-12
0.205 2024-11-13